The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 152.50
Bid: 150.00
Ask: 155.00
Change: -5.00 (-3.17%)
Spread: 5.00 (3.333%)
Open: 157.50
High: 157.50
Low: 152.50
Prev. Close: 157.50
ITX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Itaconix and Croda Renew Supply Agreement

5 Sep 2022 07:00

RNS Number : 1867Y
Itaconix PLC
05 September 2022
 

For RNS REACH release: 5 September 2022

 

Itaconix plc

("Itaconix" or the "Company")

Itaconix and Croda Renew Supply Agreement for Sustainable Odour Control

Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in plant-based specialty polymers used as essential ingredients in everyday consumer products, is pleased to announce a new global agreement with Croda Inc. ("Croda") in odour control, which serves to extend a supply collaboration that began in 2017.

Under the terms of the new supply agreement, Itaconix will continue to produce and supply the proprietary ZINADOR® odor neutralizing ingredients for Croda to market and sell globally in home care applications. The new agreement adds a newly formulated product to the collaboration and updates the terms and arrangements for ongoing market developments.

Scott Tuchinsky, North America Business Head Consumer Care at Croda, commented:

"The ZINADOR® products are an important part of our plans to continue growing our leadership position in sensory technologies and solutions. We have established a global customer base for these products through our initial efforts and see attractive opportunities for further success as more brands and consumers choose the performance and sustainability benefits of Itaconix polymer technologies."

John R. Shaw, CEO of Itaconix, added:

"Our collaboration with Croda is bringing the value of our odour neutralisation to more customers around the world in a growing range of fabric and air care products. We are pleased with Croda's continued commitment to working with Itaconix, and are excited that this new agreement expands our partnership. I expect continued progress in brand usage and new applications through our joint efforts."

 

- Ends -

 

For further information please contact:

Itaconix plc

+1 603 775 4400

John R. Shaw / Laura Denner

Belvedere Communications

+44 (0) 20 3576 0320

John West / Llew Angus

finnCap

+44 (0) 20 7220 0500

Ed Frisby / Abigail Kelly / Milesh Hindocha (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

 

About Itaconix

Itaconix uses its proprietary plant-based polymer technology platform to produce and sell specialty ingredients that improve the safety, performance, and sustainability of consumer products. The Company's current ingredients are enabling and leading new generations of products in cleaning, hygiene, and beauty. Itaconix's contributions to the global low carbon economy are recognised by the London Stock Exchange's Green Economy Mark.

www.itaconix.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASSSEEDEESEEU
Date   Source Headline
20th Nov 20137:00 amRNSMarketing approval of nicotine gum in Europe
17th Oct 20137:00 amRNSSupply and Distribution Agreement with Amma Polska
11th Oct 20137:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
25th Sep 20137:00 amRNSInterim Results
1st Aug 20137:00 amRNSTotal Voting Rights
22nd Jul 20137:00 amRNSAward of contract to supply nicotine gum
15th Jul 201312:20 pmRNSChange of Registered Office
9th Jul 20137:00 amRNSBlocklisting Interim Review
28th May 20132:02 pmRNSResult of AGM
17th Apr 20134:47 pmRNSHolding(s) in Company
17th Apr 20137:00 amRNSDirector's Dealings
9th Apr 20137:00 amRNSPositive test results for encapsulation technology
22nd Mar 20137:00 amRNSNotice of AGM and Posting of Annual Report
13th Mar 20137:00 amRNSPreliminary Results
1st Mar 20137:00 amRNSTotal Voting Rights
1st Feb 20132:42 pmRNSNotice of patent infringement proceedings
10th Jan 20137:01 amRNSAwards under Long Term Incentive Plan
10th Jan 20137:00 amRNSBlock Listing
8th Jan 20131:59 pmRNSHolding(s) in Company
19th Dec 20122:14 pmRNSEstablishment of Employee Benefit Trust
19th Dec 20127:00 amRNSTrading Update
25th Sep 20127:00 amRNSInterim Results
13th Sep 20127:00 amRNSBoard Appointment
17th Aug 20127:00 amRNSIssue of Warrants
30th Jul 20127:00 amRNSCanadian Distribution Deals Won
10th Jul 20128:09 amRNSBoard Appointment
10th Jul 20128:05 amRNSAIM Admission - First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.